These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 2892601)
1. Identification of gp108, a pathogenic antigen of passive Heymann nephritis, as dipeptidyl peptidase IV. Natori Y; Hayakawa I; Shibata S Clin Exp Immunol; 1987 Nov; 70(2):434-9. PubMed ID: 2892601 [TBL] [Abstract][Full Text] [Related]
2. Passive Heymann nephritis with acute and severe proteinuria induced by heterologous antibody against renal tubular brush border glycoprotein gp108. Natori Y; Hayakawa I; Shibata S Lab Invest; 1986 Jul; 55(1):63-70. PubMed ID: 3755192 [TBL] [Abstract][Full Text] [Related]
3. Synergistic effects of anti-gp330 and anti-dipeptidyl peptidase type IV antibodies in the induction of glomerular damage. van Leer EH; de Roo GM; Bruijn JA; Hoedemaeker PJ; de Heer E Exp Nephrol; 1993; 1(5):292-300. PubMed ID: 7915960 [TBL] [Abstract][Full Text] [Related]
4. Role of dipeptidyl peptidase IV (gp 108) in passive Heymann nephritis. Use of dipeptidyl peptidase IV-deficient rats. Natorio Y; Hayakawa I; Shibata S Am J Pathol; 1989 Feb; 134(2):405-10. PubMed ID: 2563637 [TBL] [Abstract][Full Text] [Related]
5. Nephritogenic and non-nephritogenic epithelial antigens in autoimmune and passive Heymann nephritis. Miettinen A; Törnroth T; Ekblom P; Virtanen I; Linder E Lab Invest; 1984 Apr; 50(4):435-46. PubMed ID: 6708453 [TBL] [Abstract][Full Text] [Related]
6. Heymann nephritis: a model of human membranous glomerulopathy. A study of the role of additional antigens. van Leer EH; Ronco P; Verroust P; de Roo GM; Hoedemaeker PJ; de Heer E Nephrol Dial Transplant; 1992; 7 Suppl 1():1-8. PubMed ID: 1362800 [No Abstract] [Full Text] [Related]
7. Isolation and characterization of rat nephritogenic and non nephritogenic brush border antigens. Kawai H; Yano S; Naruse T Clin Exp Immunol; 1986 Nov; 66(2):414-22. PubMed ID: 2949900 [TBL] [Abstract][Full Text] [Related]
8. Redistribution of glomerular dipeptidyl peptidase type IV in experimental lupus nephritis. Demonstration of decreased enzyme activity at the ultrastructural level. van Leer EH; Bruijn JA; Prins FA; Hoedemaeker PJ; de Heer E Lab Invest; 1993 May; 68(5):550-6. PubMed ID: 8098785 [TBL] [Abstract][Full Text] [Related]
9. The detection and characterization of renal brush border antigen (gp108) in various rat tissues. Natori Y; Hayakawa I; Shibata S Clin Exp Immunol; 1987 Jan; 67(1):135-41. PubMed ID: 3304735 [TBL] [Abstract][Full Text] [Related]
11. Biochemical and immunological properties of urinary angiotensinase A and dipeptidylaminopeptidase IV. Their use as markers in patients with renal cell injury. Scherberich JE; Wiemer J; Schoeppe W Eur J Clin Chem Clin Biochem; 1992 Oct; 30(10):663-8. PubMed ID: 1362894 [TBL] [Abstract][Full Text] [Related]
12. Passive Heymann nephritis induced by rabbit antiserum to membrane antigens isolated from rat visceral yolk-sac microvilli. Leung CC; Cheewatrakoolpong B; O'Mara T; Black M Am J Anat; 1987 Jun; 179(2):169-74. PubMed ID: 3303894 [TBL] [Abstract][Full Text] [Related]
13. Antigenic targets in epimembranous glomerulonephritis. Experimental data and potential application in human pathology. Ronco P; Allegri L; Brianti E; Chatelet F; Van Leer EH; Verroust P Appl Pathol; 1989; 7(2):85-98. PubMed ID: 2567175 [TBL] [Abstract][Full Text] [Related]
14. Role of autoantibodies against tubular brush border antigens in tubulointerstitial nephritis associated with Heymann nephritis. Kaji T; Yano S; Nojima Y; Naruse T Res Commun Mol Pathol Pharmacol; 1999; 104(1):53-62. PubMed ID: 10604278 [TBL] [Abstract][Full Text] [Related]
15. Forskolin blocks the apical expression of dipeptidyl peptidase IV in Caco-2 cells and induces its retention in lamp-1-containing vesicles. Baricault L; Garcia M; Cibert C; Sapin C; Geraud G; Codogno P; Trugnan G Exp Cell Res; 1993 Dec; 209(2):277-87. PubMed ID: 7903248 [TBL] [Abstract][Full Text] [Related]
16. Characterization of the antigen (gp600) of Heymann nephritis. Makker SP; Singh AK Lab Invest; 1984 Mar; 50(3):287-93. PubMed ID: 6199583 [TBL] [Abstract][Full Text] [Related]
17. Evidence that thymocyte-activating molecule is mouse CD26 (dipeptidyl peptidase IV). Vivier I; Marguet D; Naquet P; Bonicel J; Black D; Li CX; Bernard AM; Gorvel JP; Pierres M J Immunol; 1991 Jul; 147(2):447-54. PubMed ID: 1712807 [TBL] [Abstract][Full Text] [Related]
18. Epitope specificity of anti-gp330 autoantibodies determines the development of proteinuria in active Heymann nephritis. Van Leer EH; Ronco P; Verroust P; van der Wal AM; Hoedemaeker PJ; De Heer E Am J Pathol; 1993 Mar; 142(3):821-9. PubMed ID: 7681258 [TBL] [Abstract][Full Text] [Related]
19. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis. Susani M; Schulze M; Exner M; Kerjaschki D Am J Pathol; 1994 Apr; 144(4):807-19. PubMed ID: 8160779 [TBL] [Abstract][Full Text] [Related]
20. Proteinuria induced by anti-dipeptidyl peptidase IV (gp108); role of circulating and glomerular antigen. Natori Y; Shindo N; Natori Y Clin Exp Immunol; 1994 Feb; 95(2):327-32. PubMed ID: 7905795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]